Stroke, craniocerebral injury, brain tumor
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients diagnosed with stroke, traumatic brain injury, brain tumors, etc., within 90 days by CT or MRI; (2) Aged between 30 and 75 years old, regardless of gender; (3) Rehabilitation patients with limb motor dysfunction (Brunnstrom stage II to VI for upper and/or lower limbs in hemiplegia motor function assessment) within 180 days after onset, with stable condition; (4) Clear cognition, able to follow the research protocol; (5) The subjects understand the purpose of the study, demonstrate sufficient compliance with the research protocol, and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Significant cognitive or consciousness impairments that prevent the completion of the Fugl-Meyer scale assessment; (2) Other significant limb pathologies, such as fractures, severe arthritis, amputations, etc.; (3) Formation of joint contractures in limbs; (4) Patients with legal disabilities, such as blindness, deafness, muteness, intellectual disabilities, mental disorders, or physical disabilities; (5) Patients with severe primary diseases of the cardiovascular, liver, kidney, and hematopoietic systems, or those with psychiatric disorders; (6) Fertile women with positive urine pregnancy test results; (7) Individuals who have participated in other drug/device clinical research within 90 days prior to screening; (8) Individuals carrying active metal devices internally, such as pacemakers, etc.; (9) Other individuals deemed by the researchers as unsuitable for participation in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fugl-meyer assessment score; | — |
Secondary
| Measure | Time frame |
|---|---|
| The determination coefficient between Fugl-Meyer intelligent assessment and actual assessment;Accuracy of activity recognition; | — |
Countries
China
Contacts
General Hospital of the People's Liberation Army of China